Clinical impact of suboptimal RAASi therapy following an episode of hyperkalemia

By sjmartinez • January 20, 2023

Kanda E, Rastogi A, Murohara T, Lesén E, Agiro A, Arnold M, Chen G, Yajima T, Järbrink K, Pollack CV Jr. Clinical impact of suboptimal RAASi therapy following an episode of hyperkalemia. BMC Nephrol. 2023 Jan 19;24(1):18. doi: 10.1186/s12882-022-03054-5. PMID: 36658531.

Tags: Chronic kidney disease, Guideline-directed medical therapy, heart failure, Hyperkalemia, Nephrology, Potassium binder, Publications

The sigma1 receptor is a target for the development of cardioprotective drugs

Maslov LN, Tsirulnikov K, Slidnevskaya AS, Kilin M, Kan A, Grab AE, Gorbunov AS, Singh N. The σ1receptor is a target for the development of[...]

Calcific Changes in an End-Stage Kidney following Long-Term Dialysis, Tertiary Hyperparathyroidism, and Treatment for Complement-Mediated Thrombotic Microangiopathy: A Case Report

Shah KG, Adler SG, Dai T, Nast CC. Calcific Changes in an End-Stage Kidney following Long-Term Dialysis, Tertiary Hyperparathyroidism, and Treatment for Complement-Mediated Thrombotic Microangiopathy:[...]

The Role of Online Hemodiafiltration in Contemporary Kidney Care

Ronco C, Maduell F, Kalantar-Zadeh K, Madero M, Reis T. The Role of Online Hemodiafiltration in Contemporary Kidney Care. Clin J Am Soc Nephrol. 2025[...]